↓ Skip to main content

Structure-based drug design, synthesis and biological assays of P. falciparum Atg3–Atg8 protein–protein interaction inhibitors

Overview of attention for article published in Perspectives in Drug Discovery and Design, January 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
23 Mendeley
Title
Structure-based drug design, synthesis and biological assays of P. falciparum Atg3–Atg8 protein–protein interaction inhibitors
Published in
Perspectives in Drug Discovery and Design, January 2018
DOI 10.1007/s10822-018-0102-5
Pubmed ID
Authors

Stefania Villa, Laura Legnani, Diego Colombo, Arianna Gelain, Carmen Lammi, Daniele Bongiorno, Denise P. Ilboudo, Kellen E. McGee, Jürgen Bosch, Giovanni Grazioso

Abstract

The proteins involved in the autophagy (Atg) pathway have recently been considered promising targets for the development of new antimalarial drugs. In particular, inhibitors of the protein-protein interaction (PPI) between Atg3 and Atg8 of Plasmodium falciparum retarded the blood- and liver-stages of parasite growth. In this paper, we used computational techniques to design a new class of peptidomimetics mimicking the Atg3 interaction motif, which were then synthesized by click-chemistry. Surface plasmon resonance has been employed to measure the ability of these compounds to inhibit the Atg3-Atg8 reciprocal protein-protein interaction. Moreover, P. falciparum growth inhibition in red blood cell cultures was evaluated as well as the cyto-toxicity of the compounds.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 22%
Researcher 4 17%
Student > Ph. D. Student 3 13%
Student > Bachelor 2 9%
Student > Doctoral Student 1 4%
Other 1 4%
Unknown 7 30%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Agricultural and Biological Sciences 3 13%
Chemistry 3 13%
Biochemistry, Genetics and Molecular Biology 2 9%
Immunology and Microbiology 2 9%
Other 1 4%
Unknown 8 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2018.
All research outputs
#16,784,715
of 25,461,852 outputs
Outputs from Perspectives in Drug Discovery and Design
#720
of 949 outputs
Outputs of similar age
#271,375
of 449,716 outputs
Outputs of similar age from Perspectives in Drug Discovery and Design
#7
of 13 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 949 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,716 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.